A patent on breast cancer genes? Yes, says court

A U.S. federal appeals court has affirmed the right of Myriad Genetics to patent two human genes that form the basis of a widely used genetic test for breast and ovarian cancers. Opponents argued that it’s immoral and unethical to patent human DNA.

A U.S. federal appeals court has affirmed the right of Myriad Genetics to patent two human genes that form the basis of a widely used genetic test for breast and ovarian cancers. Opponents argued that it’s immoral and unethical to patent human DNA.

Leave a Reply

Your email address will not be published. Required fields are marked *

Connect with Facebook

Read the original at msnbc.com: Cancer.